Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Is Cenovus Energy Inc. (TSX:CVE) a Contrarian Buy Today?

Published 2018-11-09, 05:49 p/m
Updated 2018-11-09, 06:15 p/m
Is Cenovus Energy Inc. (TSX:CVE) a Contrarian Buy Today?

The recent plunge in oil prices is taking a toll on Canadian oil producers, and some stocks are now down to levels that could be attractive.

Many investors are simply giving the sector a wide berth regardless of how cheap the stocks look, but those with a contrarian style might want to start kicking the tires on a few names in the industry.

Let’s take a look at Cenovus Energy (TSX:CVE)(NYSE:CVE) to see if it deserves to be on your buy list right now.

Big acquisition

Cenovus made a huge bet on the future of the Canadian oil market last year when it spent $17.7 to buy out its oil sands partner, ConocoPhillips (NYSE:COP). The deal instantly doubled production and the resource base at the oil sands operations, which Cenovus already operated, and came with key assets in the growing Deep Basin plays.

Unfortunately, Cenovus had to sell a portfolio of non-core assets at cheap prices to cover a $3.6 billion bridge loan it used to close the acquisition. In addition, management entered hedging positions on 80% of production through the first half of 2018 at prices that were significantly lower than where the market ended up in that time frame. As a result, the company booked a risk management loss of $469 million in Q1 and $697 million in Q2 2018.

On the positive side, most of that pain should be over, and Cenovus delivered a decent third quarter. The company generated free funds flow of $700 million in the quarter supported by improved performance and margins at the refining operations and higher year-over-year oil prices compared to Q3 2017.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Net debt dropped $1.6 billion, as Cenovus used cash from operations and the $625 million in proceeds from an asset sale to strengthen the balance sheet.

Pipeline bottlenecks remain an issue, as Cenovus sells a good chunk of production at the discounted Western Canadian Select price. However, the company is still putting up solid numbers.

Cenovus currently trades at $12 per share. That’s better than the $9 low it hit in early 2018, but is still significantly off the $30 per share price it fetched in 2014.

Should you buy?

Despite the pipeline challenges, Cenovus appears to be on the mend, and management has even floated the idea of a dividend increase next year. The company will start moving more oil by rail to improve its sale price, and while oil prices have pulled back off the summer highs, they remain well above where they were last year, and could take off again in 2019 amid global supply risks, including U.S. sanctions against Iran.

If you are an oil bull, and can ride out additional near-term volatility, Cenovus might be an interesting contrarian pick today.

Fool contributor Andrew Walker has no position in any stock mentioned.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.